valcyte 50 mg/ml prašak za oralnu otopinu
cheplapharm arzneimittel gmbh, ziegelhof 24, greifswald, njemačka - valganciklovirklorid - prašak za oralnu otopinu - 50 mg/ml - urbroj: jedna boca sadrži 5,5 g valganciklovirklorida po 12 g praška za oralnu otopinu 1 ml rekonstituirane otopine sadrži 50 mg valganciklovira (u obliku klorida)
valganciklovir pliva 450 mg filmom obložene tablete
pliva hrvatska d.o.o., prilaz baruna filipovića 25, zagreb, hrvatska - valganciklovirklorid - filmom obložena tableta - 450 mg - urbroj: jedna filmom obložena tableta sadrži 450 mg valganciklovira, u obliku valganciklovirklorida
rinvoq
abbvie deutschland gmbh & co. kg - upadacitinib - artritis, reumatoidni - imunosupresivi - rheumatoid arthritisrinvoq is indicated for the treatment of moderate to severe active rheumatoid arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more disease-modifying anti-rheumatic drugs (dmards). rinvoq may be used as monotherapy or in combination with methotrexate. psoriatic arthritisrinvoq is indicated for the treatment of active psoriatic arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more dmards. rinvoq may be used as monotherapy or in combination with methotrexate. axial spondyloarthritisnon-radiographic axial spondyloarthritis (nr-axspa)rinvoq is indicated for the treatment of active non-radiographic axial spondyloarthritis in adult patients with objective signs of inflammation as indicated by elevated c-reactive protein (crp) and/or magnetic resonance imaging (mri), who have responded inadequately to nonsteroidal anti-inflammatory drugs (nsaids). ankylosing spondylitis (as, radiographic axial spondyloarthritis)rinvoq is indicated for the treatment of active ankylosing spondylitis in adult patients who have responded inadequately to conventional therapy. atopic dermatitisrinvoq is indicated for the treatment of moderate to severe atopic dermatitis in adults and adolescents 12 years and older who are candidates for systemic therapy. ulcerative colitisrinvoq is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis who have had an inadequate response, lost response or were intolerant to either conventional therapy or a biologic agent. crohn’s diseaserinvoq is indicated for the treatment of adult patients with moderately to severely active crohn’s disease who have had an inadequate response, lost response or were intolerant to either conventional therapy or a biologic agent.
temybric ellipta
glaxosmithkline trading services limited - flutikazon furoat, umeclidinium bromid, vilanterol trifenatat - plućna bolest, kronična opstruktivna - lijekovi za opstruktivne plućne bolesti dišnih putova, - temybric ellipta navodi kao terapiju održavanja u odraslih bolesnika s umjerenom do teškom kroničnom opstruktivnom plućnom bolesti (kopb), koja se ne liječi ispravno kombinacija inhalacijskim kortikosteroidima i trajno djeluju β2-agonista ili kombinacije trajno djeluju β2-agonista i длинн-djeluje мускаринового antagonist (za izlaganje na simptom kontrolu i prevenciju pogoršanja vidi odjeljak 5.
ibuprofen hf 400 mg/1 tableta film tableta
hemofarm proizvodnja farmaceutskih proizvoda d.o.o. banja luka - ibuprofen - film tableta - 400 mg/1 tableta - 1 film tableta sadrži: 400 mg ibuprofen
febricet 120 mg/5 ml sirup
hemofarm proizvodnja farmaceutskih proizvoda d.o.o. banja luka - paracetamol - sirup - 120 mg/5 ml - 5 ml sirupa sadrži: 120 mg paracetamola
kofan instant 200 mg/1 tableta+ 200 mg/1 tableta+ 50 mg/1 tableta tableta
bosnalijek d.d. - kofein, paracetamol, propifenazon - tableta - 200 mg/1 tableta+ 200 mg/1 tableta+ 50 mg/1 tableta - 1 tableta sadrži: 200 mg paracetamol 200 mg propifenazon 50 mg kofein
kofan instant 200 mg/1 tableta+ 200 mg/1 tableta+ 50 mg/1 tableta tableta
bosnalijek d.d. - kofein, paracetamol, propifenazon - tableta - 200 mg/1 tableta+ 200 mg/1 tableta+ 50 mg/1 tableta - 1 tableta sadrži: 200 mg paracetamol 200 mg propifenazon 50 mg kofein
kombinovani prašak hf 400 mg/1 kesica+ 50 mg/1 kesica prašak za oralni rastvor
hemofarm proizvodnja farmaceutskih proizvoda d.o.o. banja luka - kofein, paracetamol - prašak za oralni rastvor - 400 mg/1 kesica+ 50 mg/1 kesica - 1 kesica sa praškom za oralni rastvor sadrži: 400 mg paracetamola 50 mg kofeina
kombinovani prašak hf 400 mg/1 kesica+ 50 mg/1 kesica prašak za oralni rastvor
hemofarm proizvodnja farmaceutskih proizvoda d.o.o. banja luka - kofein, paracetamol - prašak za oralni rastvor - 400 mg/1 kesica+ 50 mg/1 kesica - 1 kesica sa praškom za oralni rastvor sadrži: 400 mg paracetamola 50 mg kofeina